Aayush Wellness Shares Gain Nearly 7 per cent After Q2 FY27 Results, H1 Net Profit Rises 6 per cent
हमसे जुड़ें
हमें फ़ॉलो करें
The company intends to further expand its offerings across nutraceuticals, herbal wellness and lifestyle-focused healthcare products.
✨ मुख्य निष्कर्ष
Aayush Wellness Limited (BSE: 539528) witnessed buying interest on Wednesday, November 4, 2026, with its shares rising nearly 7 per cent during Intraday trade following the announcement of its financial results for the quarter and half year ended September 30, 2026. The stock touched an intraday high of Rs 27 against its previous closing price of Rs 25.32.
For the first half of FY27 (H1 FY27), the company reported consolidated income of Rs 70.62 crore, registering growth of 10.61 per cent compared to Rs 63.85 crore in the corresponding period last year. Consolidated profit after Tax (PAT) increased by approximately 6 per cent to Rs 2.50 crore from Rs 2.36 crore.
During Q2 FY27, consolidated income stood at Rs 36.86 crore, reflecting sequential growth of 9.17 per cent from Rs 33.76 crore reported in Q1 FY27. However, consolidated PAT for the quarter stood at Rs 1.08 crore, compared to an implied Rs 1.42 crore in the preceding quarter, indicating a decline in quarterly profitability despite higher income.
On a standalone basis, income increased sequentially by 6.77 per cent to Rs 26.39 crore from Rs 24.72 crore in Q1 FY27. Profit before tax (PBT) rose to Rs 1.35 crore from Rs 1.19 crore during the same period.
For H1 FY27, standalone income stood at Rs 51.11 crore, while PBT increased by 7.56 per cent to Rs 2.55 crore.
Apart from its financial performance, Aayush Wellness has been expanding its product portfolio in the preventive healthcare and nutraceutical segments. The company launched Aayush Calcium Vitamin Tablets in October, marking its entry into the bone and joint health category. This followed the launch of Lung Care Tablets in August and Dia Shield Tablets in May, targeting respiratory health and metabolic wellness, respectively.
The company intends to further expand its offerings across nutraceuticals, herbal wellness and lifestyle-focused healthcare products. It also plans to strengthen consumer access through digital commerce and distribution channels as part of its broader business expansion strategy.